Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PR
5201
CALL
Permian Resources
PR
$18B
| $2.26M | ﹤0.01% |
378,200
+32,500
| +9% | +$260K |
|
|
SURF
5202
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $2.26M | ﹤0.01% |
1,379,346
-25,870
| -2% | -$53.7K |
|
5203
CALL
Amplitude
AMPL
$1.63B
| $2.26M | ﹤0.01% |
158,200
+116,900
| +283% | +$2.05M |
|
5204
Century Communities
CCS
$2.01B
| $2.26M | ﹤0.01% |
50,285
+1,887
| +4% | +$95.3K |
|
5205
CALL
Churchill Downs
CHDN
$6.33B
| $2.26M | ﹤0.01% |
23,600
+8,200
| +53% | +$815K |
|
5206
Trustmark
TRMK
$2.8B
| $2.25M | ﹤0.01% |
77,209
+67,573
| +701% | +$1.95M |
|
5207
Endava
DAVA
$164M
| $2.25M | ﹤0.01% |
25,506
+1,379
| +6% | +$144K |
|
5208
CBIZ
CBZ
$2.96B
| $2.25M | ﹤0.01% |
+56,288
| New | +$2.27M |
|
5209
CALL
CEL-SCI Corp
CVM
$26.9M
| $2.25M | ﹤0.01% |
16,660
+757
| +5% | +$78.9K |
|
|
GOLD
5210
CALL
Gold.com Inc
GOLD
$1.28B
| $2.25M | ﹤0.01% |
69,700
-18,100
| -21% | -$650K |
|
5211
State Street SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF
EEMX
$179M
| $2.25M | ﹤0.01% |
73,532
+53,896
| +274% | +$1.72M |
|
|
PLL
5212
PUT
DELISTED
Piedmont Lithium
PLL
| $2.25M | ﹤0.01% |
61,700
+31,400
| +104% | +$1.86M |
|
5213
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
| $2.25M | ﹤0.01% |
36,739
+21,203
| +136% | +$1.3M |
|
5214
CALL
Schwab US Large- Cap ETF
SCHX
$74.9B
| $2.25M | ﹤0.01% |
150,900
-19,800
| -12% | -$321K |
|
5215
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$784M
| $2.24M | ﹤0.01% |
16,760
+12,400
| +284% | +$1.8M |
|
5216
PUT
State Street SPDR S&P Dividend ETF
SDY
$22.2B
| $2.24M | ﹤0.01% |
18,900
+8,600
| +83% | +$1.07M |
|
|
IPOD
5217
CALL
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $2.24M | ﹤0.01% |
225,800
+23,000
| +11% | +$231K |
|
5218
ASE Group
ASX
$103B
| $2.24M | ﹤0.01% |
433,492
+188,710
| +77% | +$1.26M |
|
5219
CALL
First Interstate BancSystem
FIBK
$3.73B
| $2.24M | ﹤0.01% |
58,800
+12,100
| +26% | +$431K |
|
5220
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.42B
| $2.23M | ﹤0.01% |
29,157
+2,017
| +7% | +$169K |
|
|
LONA
5221
CALL
LeonaBio Inc
LONA
$74.8M
| $2.23M | ﹤0.01% |
73,230
+27,180
| +59% | +$2.49M |
|
5222
Timothy Plan High Dividend Stock ETF
TPHD
$373M
| $2.23M | ﹤0.01% |
+75,453
| New | +$2.4M |
|
|
ZUO
5223
DELISTED
Zuora, Inc.
ZUO
| $2.23M | ﹤0.01% |
249,622
+172,444
| +223% | +$1.92M |
|
5224
Turning Point Brands
TPB
$1.75B
| $2.23M | ﹤0.01% |
82,311
-62,043
| -43% | -$1.82M |
|
|
IBER
5225
DELISTED
Ibere Pharmaceuticals
IBER
| $2.23M | ﹤0.01% |
227,698
-550,000
| -71% | -$5.39M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.